GlassScriptPhysician profile
Robert G Salazar
NPI 1104841253
$24,902.91
in general payments reported to CMS, 2019-2025
21 companies · $3,956 in 2025
The $3,956 reported for 2025 was more than what 91% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,168 · 2020: $8,043 · 2021: $4,352 · 2022: $1,877 · 2023: $4,476 · 2024: $1,031 · 2025: $3,956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Food and Beverage: $4,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Food and Beverage | $4,462.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,173.42 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Medtronic USA, INC. | $7,890.89 | 2019-2020 | |
| Abbott Laboratories | $2,604.81 | 2021-2025 | Proclaim |
| Vertos Medical, INC. | $835.37 | 2020-2024 | Mild Device Kit |
| Boston Scientific Corporation | $759.91 | 2020-2025 | General - Pain Management, Intracept |
| Painteq LLC | $316.85 | 2022 | |
| Nevro Corp. | $234.98 | 2019-2023 | Senza |
| Relievant Medsystems, INC. | $194.48 | 2021-2023 | Intracept |
| Vertiflex, INC. | $180.83 | 2019 | |
| Stimwave Technologies Incorporated | $143.06 | 2020-2022 | |
| Flowonix Medical Incorporated | $130.53 | 2019 | |
| Forte Bio-Pharma LLC | $112.36 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Axsome Therapeutics, INC. | $59.93 | 2024-2025 | Sunosi |
| Kowa Pharmaceuticals America, INC. | $55.00 | 2022-2023 | Seglentis |
| Merz Pharmaceuticals, LLC | $48.15 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $42.45 | 2022-2024 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $38.62 | 2025 | |
| Horizon Therapeutics Plc | $24.88 | 2021 | |
| Scilex Pharmaceuticals INC. | $21.51 | 2022 | |
| Si-Bone, INC. | $17.88 | 2022 | |
| Curonix LLC | $17.00 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Salazar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.